ANTI-CD19 COMBINATION THERAPY Application WO-2022117799-A2 World Intellectual Property Organisation (WIPO) 09 Jun 2022
HER2-targeting molecules comprising de-immunized, Shiga toxin A subunit scaffolds Grant US-11225509-B2 United States of America 18 Jan 2022
ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF LEUKEMIA OR… Application US-20210130460-A1 United States of America 06 May 2021